Possible involvement of Syndecan-1 in the state of COVID-19 related to endothelial injury
Abstract Background The coronavirus infection 2019 (COVID-19) is associated with microvascular endothelial injury. Here, we report that syndecan-1, a component of endothelial glycocalyx, may reflect the disease state of COVID-19 related to endothelial injury. Case presentation A patient with COVID-1...
Main Authors: | Keiko Suzuki, Hideshi Okada, Hiroyuki Tomita, Kazuyuki Sumi, Yoshinori Kakino, Ryu Yasuda, Yuichiro Kitagawa, Tetsuya Fukuta, Takahito Miyake, Shozo Yoshida, Akio Suzuki, Shinji Ogura |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | Thrombosis Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12959-021-00258-x |
Similar Items
-
Syndecan-1 as a severity biomarker for patients with trauma
by: Keiko Suzuki, et al.
Published: (2022-09-01) -
Serum syndecan-1 concentration in hemolysis, elevated liver enzymes, and low platelets syndrome: A case report
by: Ayane Nishio, et al.
Published: (2023-03-01) -
Measuring the Concentration of Serum Syndecan-1 to Assess Vascular Endothelial Glycocalyx Injury During Hemodialysis
by: Keigo Kusuzawa, et al.
Published: (2021-12-01) -
Serum syndecan-1 reflects organ dysfunction in critically ill patients
by: Keiko Suzuki, et al.
Published: (2021-04-01) -
Circulating Syndecan-1 as a Predictor of Persistent Thrombocytopenia and Lethal Outcome: A Population Study of Patients With Suspected Sepsis Requiring Intensive Care
by: Kosaku Hatanaka, et al.
Published: (2021-09-01)